BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23504338)

  • 1. Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis.
    Le Rhun E; Tu Q; De Carvalho Bittencourt M; Farre I; Mortier L; Cai H; Kohler C; Faure GC
    Med Oncol; 2013 Jun; 30(2):538. PubMed ID: 23504338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis.
    Le Rhun E; Massin F; Tu Q; Bonneterre J; Bittencourt Mde C; Faure GC
    BMC Clin Pathol; 2012 Nov; 12():21. PubMed ID: 23145812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis.
    Tu Q; Wu X; Le Rhun E; Blonski M; Wittwer B; Taillandier L; De Carvalho Bittencourt M; Faure GC
    Lung Cancer; 2015 Nov; 90(2):352-7. PubMed ID: 26386833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
    Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
    Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
    Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
    J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.
    Cho JH; Sim MH; Kim SY; Kim K; Lee T; Lee J; Kang WK; Kim ST
    J Cancer Res Ther; 2021; 17(4):1047-1051. PubMed ID: 34528562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
    Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
    J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
    Lin Y; Yu T; Li H; Yin Z; Guo A
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid.
    van Bussel MTJ; Pluim D; Bol M; Beijnen JH; Schellens JHM; Brandsma D
    J Neurooncol; 2018 Mar; 137(1):1-10. PubMed ID: 29192390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.
    Cordone I; Masi S; Summa V; Carosi M; Vidiri A; Fabi A; Pasquale A; Conti L; Rosito I; Carapella CM; Villani V; Pace A
    Breast Cancer Res; 2017 Apr; 19(1):46. PubMed ID: 28399903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study.
    Darlix A; Cayrefourcq L; Pouderoux S; Menjot de Champfleur N; Bievelez A; Jacot W; Leaha C; Thezenas S; Alix-Panabières C
    Clin Chem; 2022 Oct; 68(10):1311-1322. PubMed ID: 35953885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral magnetic resonance imaging (MRI) in the diagnosis of leptomeningeal carcinomatosis in melanoma patients].
    Dupuis F; Sigal R; Margulis A; Mercier S; Spatz A; Mamelle G; Lartigau E; Duvillard P; Avril MF
    Ann Dermatol Venereol; 2000 Jan; 127(1):29-32. PubMed ID: 10717559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
    Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
    Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
    Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thinprep plus Papanicolaou stain method is more sensitive than cytospin-coupled Wright Giems stain method in cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis from solid tumors.
    Pan Z; Yang G; Wang Y; He H; Pang X; Gao Y; Shi W; Li Y; Dong L; Song Y
    PLoS One; 2015; 10(4):e0122016. PubMed ID: 25850010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
    Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
    Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of meningeal melanomatosis diagnosed by immunostaining of cerebrospinal fluid].
    Tamura Y; Umeda Y; Umeda M; Oyake M; Usuda H; Fujita N
    Rinsho Shinkeigaku; 2020 Aug; 60(8):565-568. PubMed ID: 32641630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
    Lin Y; Li H; Huang M; Yin Z; Wu J
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.